Introduction {#s1}
============

Members of the Gram-negative *Enterobacteriaceae* have caused significant diseases throughout human history. They are responsible for many human infections in the intestine, urinary tract, bloodstream, and wounds (Abbott, [@B1]; Shanks et al., [@B66]). The genus *Citrobacter* belongs to this bacterial family, although it was originally classified within the genus *Salmonella* due to biochemical and serological similarities (Harhoff, [@B32]; Ewing and Davis, [@B25]). *Citrobacter freundii* is the type species of this genus, with a genome size of \~5 Mb and a G+C content of 50 to 52% (Kumar et al., [@B40]; Kimura et al., [@B39]). *C. freundii* is commonly found in soil, water, foods, and the intestinal tracts of animals and humans (Drelichman and Band, [@B22]). Some strains of *C. freundii* can also cause opportunistic infections in humans and animals, which are becoming more difficult to treat due to increased antibiotic resistance. As such, *C. freundii* infections have become a public health concern (Samonis et al., [@B61]; Antonelli et al., [@B5]; Campos et al., [@B11]) and alternatives or adjuncts to antibiotic treatment are required.

In this context, lytic/virulent phages are being re-investigated as potential antimicrobial agents to either combat bacterial diseases or to stop the dissemination of multi-resistant bacteria. The potential of phages to control or treat bacterial diseases has been previously demonstrated (Smith and Huggins, [@B71]; Slopek et al., [@B70]). However, their use was mostly abandoned for several well-documented reasons including the inability to purify phage preparations from bacterial components, the lack of understanding of basic phage biology, the inability to differentiate temperate from lytic phages, narrow host ranges, the development of phage-resistant bacterial mutants, and the inherent difficulties of patenting phages and their use. It is believed that progress has been made to overcome most, if not all, these difficulties (Carlton, [@B12]; Loc-Carrillo and Abedon, [@B48]).

Several phages infecting various strains of *C. freundii* have been recently characterized. Six of them belong to the *Myoviridae* family \[double-stranded DNA genome (dsDNA), contractile tail\] and were isolated from water samples in Texas. Their genomic characterization indicated that three of these phages (Moon, Miller, Merlin) are related to the *T4virus* genus (Edwards et al., [@B24]; Hwang et al., [@B34]; LeSage et al., [@B45]) while the other three (Mordin, Michonne, Moogle) are related to the *Felixo1virus* genus (Bernal et al., [@B8]; Guan et al., [@B29]; Nguyen et al., [@B54]). The complete genomic sequence of the *C. freundii* phage Stevie is also available (Shaw et al., [@B67]). This *Siphoviridae* phage (dsDNA, noncontractile tail), which was isolated from a dirt sample in Texas, is related to the *T1virus* genus. Phages of the *Podoviridae* family (dsDNA, short tail) can also infect *C. freundii* strains as the podophage LK1 was isolated from sewage and its genome size was estimated to be 20--23 kb (Chaudhry et al., [@B13]). The podophage phiCFP-1 was isolated from sewage in China and classified as a *T7virus* with a genome of 38,625 bp with 43 *orfs* and direct terminal repeats of 229 bp (Zhao et al., [@B78]).

Phages belonging to the *T7virus* genus are particularly interesting for therapeutic applications as they are usually easy to culture and have a short lytic cycle. They also have smaller genomes and a conserved organization, which facilitates their in-depth analysis. Their genomes can be divided into three transcriptional regions including early-, middle-, and late-expressed genes (Scholl and Merril, [@B65]; Zhu et al., [@B80]). As for the prototype coliphage T7, the genes of these phages can be transcribed due to an efficient phage-encoded RNA polymerase that specifically recognizes a set of conserved promoters dispersed throughout the phage genome (Chen and Schneider, [@B14]; Huang et al., [@B33]).

Here, we describe five lytic *Podoviridae* phages infecting *C. freundii* isolated from sewage samples in Tunisia. Their analyses showed that they belong to the *Autographivirinae* subfamily and they share similarities with phages infecting other *Enterobacteriaceae.*

Materials and methods {#s2}
=====================

Bacterial strains, phage isolation, and culture conditions
----------------------------------------------------------

Five bacterial isolates were obtained by plating Tunisian wastewater samples on *Salmonella*-*Shigella* agar (Biokar) and incubating the plates for 24 h at 37°C. The species of each bacterial isolate was determined by 16S rRNA sequencing and API 20 E strip (BioMérieux). *C. freundii* strains were genotyped using multi-locus sequence typing (MLST) of seven housekeeping genes (*aspC, clpX, fadD, mdh, arcA, dnaG*, and *lysP*) as described previously (Bai et al., [@B7]). The allelic profile and sequence type (ST) of each strain was identified using the MLST database website (<http://pubmlst.org/cfreundii/>). Evolutionary analyses were conducted with MEGA7 (Kumar et al., [@B41]). The neighbor-joining phylogenetic tree (Saitou and Nei, [@B59]) of the five strains was generated from the concatenated sequences of the seven loci. The evolutionary distances were computed using the Maximum Composite Likelihood method (Tamura et al., [@B76]) and are in the units of the number of base substitutions per site.

Two *C. freundii* isolates were used as hosts for phage isolation. Water samples were obtained from four different areas in Tunis (Table [1](#T1){ref-type="table"}). One millilitre of the filtered water samples was mixed with 1 ml of an overnight bacterial culture in 3 ml of Brain Heart Infusion broth (BHI) (Biokar or BD). After incubation for 24 h at 37°C, the mixtures were centrifuged and 4 μl of each filtered-supernatant was spotted on a fresh bacterial lawn. After incubation at 37°C for 24 h, phage lysis zones were picked with a sterile truncated tip and amplified in the presence of their respective host in BHI for 24 h at 37°C. Then, the mixtures were centrifuged and the supernatants filtered. Isolated plaques were obtained using the double-layer agar method and picked with a sterile truncated tip. This step was repeated three times to ensure phage purity. Phages and bacterial strains were deposited at the Félix d\'Hérelle Reference Center for Bacterial Viruses of the Université Laval ([www.phage.ulaval.ca](http://www.phage.ulaval.ca)) under the following names: phages SH1 (HER 516), SH2 (HER 517), SH3 (HER 518), SH4 (HER 519), and SH5 (HER 520) as well as *C. freundii* strains CF3 (HER 1518) and CF5 (HER 1516).

###### 

**Origins of phages and their host strains**.

  **Phage**   **Origins of phages**                        **Host strain**   **Origins of strain**
  ----------- -------------------------------------------- ----------------- -----------------------------------------
  SH1         Wadi of Khaznadar                            CF5               Entry water treatment plant of Menzah1
  SH2         Wastewater from Mellassine                   CF5               
  SH3         Office of national sanitation of Ksar Said   CF3               Entry water treatment plant of Gammarth
  SH4         Wastewater from Mellassine                   CF3               
  SH5         Wadi of Ezzouhour city                       CF3               

Microbiological assays
----------------------

The host range of the five phages was determined by spotting 4 μl of various serial dilutions (10^0^ to 10^−7^) of a phage lysates on BHI soft agar (0.75% agar) containing one bacterial strain. After overnight incubation at 37°C, plates were examined for the presence of isolated plaques in the spotted areas, which indicated a full phage lytic cycle on the host. The host range was tested on 5 *C. freundii* (this study), one *Cronobacter turicensis* (290708/07) and 25 bacterial strains available at the Félix d\'Hérelle Reference Center for Bacterial Viruses of the Université Laval: 10 *Escherichia coli* (HER1024, HER1040, HER1144, HER1255, HER1462, HER1155, HER1290, HER1022, HER1213, and HER1445), two *Shigella dysenteriae* (HER1020 and HER1031), one *Shigella sonnei* (HER1043), two *Salmonella* Paratyphi (HER1045, HER1220), one *Salmonella* Typhi (HER1038), two *Salmonella* Typhimurium (HER1023, HER1095), two *Salmonella* Newport (HER1185 and HER1019), one *Salmonella* Heidelberg (HER1428), one *Salmonella* Senftenberg (HER1397), and 3 *Yersinia enterocolitica* (HER1249, HER1071, HER1072). Phage susceptibility to pH (2 to 10) was also determined in BHI broth with the pH adjusted using hydrochloric acid (HCl) or sodium hydroxide (NaOH). One hundred microlitre of each phage lysate at \>10^9^PFU/ml were mixed with 900 μl of media for each pH condition and incubated at 37°C for 60 min. Phage titer was then determined using the double-layer agar method.

Electron microscopy
-------------------

Phages were prepared and observed as described previously (Fortier and Moineau, [@B26]). The reported dimensions are the means of at least ten virions stained with uranyl acetate (2%).

Phage structural proteins
-------------------------

Phages were precipitated from lysates (1L) with 10% polyethylene glycol (PEG) 8000 and 2922g of sodium chloride then concentrated using a discontinuous CsCl gradient followed by a continuous CsCl gradient, as described previously (Chibani Azaïez et al., [@B15]; Sambrook and Russel, [@B60]). A purified phage sample was sent directly for structural protein identification by liquid chromatography/tandem mass spectrometry (LC-MS/MS) at the Plateforme Protéomique, Centre de Génomique de Québec (Université Laval). A custom database was generated using the putative predicted proteins. Results were analyzed using Scaffold Proteome software version 4.4.5.

Genome sequencing and bioinformatics analyses
---------------------------------------------

Phage DNA was extracted from high titer phage lysates using a Plasmid Maxi Kit (Qiagen) with modifications described elsewhere (Deveau et al., [@B21]). Phage DNA was prepared for sequencing using the Nextera XT DNA library preparation kit (Illumina) according to the manufacturer\'s instructions. The libraries were then sequenced on a MiSeq system using a MiSeq reagent kit v2 (Illumina, 500 cycles). *De novo* assembly was performed with Ray assembler version 2.2.0 using *k*-mer sizes of 21, 51, 96, 31, and 51 and we obtained mean coverage depths for each single phage contig of 2717, 1643, 3804, 134, and 2431 for SH1, SH2, SH3, SH4, and SH5, respectively. Coverage was calculated with Samtools. Open reading frames (ORFs) were identified using ORF Finder (Rombel et al., [@B57]) and GeneMark (Lukashin and Borodovsky, [@B49]) then confirmed by visual inspection for the presence of a Shine-Dalgarno sequence close to a start codon (AUG, UUG or GUG) using BioEdit 7.2.0 (Hall, [@B31]). ORFs were considered if they contained at least 30 amino acids (aa). Similarities with known proteins were searched with BLAST. Hits were considered when the *E*-value was lower than 10^−3^. The percentage of identity between proteins was calculated by dividing the number of identical residues by the size of the smallest protein. The theoretical molecular weight (MW) and isoelectric point (pI) of the ORFs were calculated using the Compute pI/MW tool (<http://web.expasy.org/compute_pi/>).

Determination of genome ends
----------------------------

To confirm the direct terminal repeats, primers adjacent to the predicted terminal ends were designed using Primer-BLAST at NCBI. The putative ends were established by aligning the genome termini with similar phage genomes using ClustalW2 (<http://www.ebi.ac.uk/Tools/msa/clustalw2/>). The primers were used to sequence directly from the phage DNA at the sequencing and genotyping platform of the Université Laval using the ABI data 3730XL DNA analyzer. The primers used are described in Table [2](#T2){ref-type="table"}. Terminal repeat sequences were determined using Staden software (version 1.7.0) (Staden, [@B72]).

###### 

**Primers used to determine the terminal repeats**.

  **Phage**   **Forward primer (5′-3′)**   **Reverse primer (5′-3′)**
  ----------- ---------------------------- ----------------------------
  SH1         GCCTCACTGTTCCGTCATTT         CAACTGAAAGGAGGTGGCTC
  SH2         TGTCTCAGGGAGTGGCTTTA         GCTCAATGTTACGCTTGCTG
  SH3         GCCCTACCCCAGTCTATCAT         CTATCCCTACGCCATCTTGC
  SH4/SH5     CTGCTGTTCTACTTGCTGCT         GCTATGGTCCCTGACTGCTA

DNA polymerase phylogeny
------------------------

The DNA polymerase sequence dataset used for phylogeny included phage proteins from different families and genera (Labrie et al., [@B43]). The sequences were aligned using MAFFT with the E-INS-i parameter (Katoh and Standley, [@B38]). The alignment was then processed to generate the tree as previously described (Mercanti et al., [@B52]). Briefly, the best amino-acid substitution model implemented in PhyML 3.0 to calculate the best tree was predicted with ProtTest 3.2 (Darriba et al., [@B19]). The Shimodaira-Hasegawa-like procedure was used to determine the branch support values (Shimodaira, [@B68]). Finally, Newick utility package (Junier and Zdobnov, [@B36]) and ITOL (Letunic and Bork, [@B46]) were used to render the tree.

Nucleotide sequence accession numbers
-------------------------------------

The annotated phage genomic sequences were deposited in GenBank under the numbers [KU687347](KU687347) (SH1), [KU687348](KU687348) (SH2), [KU687349](KU687349) (SH3), [KU687350](KU687350) (SH4), [KU687351](KU687351) (SH5).

Results {#s3}
=======

Isolation of bacteria and phages
--------------------------------

Five bacterial strains were isolated from different wastewater samples. Gram staining showed Gram negative bacilli. Sequencing of 16S rRNA and API 20E strip identification revealed that they belong to the *C. freundii* species. MLST analyses showed that the five strains also belong to different genotypes, CF5 belong to ST19 and the four other strains belong to four novel and different ST. Phylogenetic analyses (Figure [1](#F1){ref-type="fig"}) revealed that CF3, CF4, and CF7 belonged to a different branch from CF5 and CF8. Two *C. freundii* isolates (CF3 and CF5) were selected from each branch and used as host organisms to isolate phages.

![**Neighbor-joining phylogenetic tree of the five strains of *Citrobacter freundii***.](fmicb-07-01023-g0001){#F1}

A total of five virulent phages, SH1, SH2, SH3, SH4, and SH5, were isolated from four sewage samples (Table [1](#T1){ref-type="table"}). For phages SH1 and SH2, plaques of 2 mm in diameter appeared after only 3 h of incubation at 37°C and the plaques became larger with diameters ranging from 4 to 6 mm after overnight incubation, as shown in Figure [2](#F2){ref-type="fig"}. Phage SH3 produced smaller plaques of 1 mm in diameter while phages SH4 and SH5 produced plaques of about 3 mm in diameter.

![**Plaques formed by phages SH1, SH2, SH3, SH4, and SH5, respectively, from left to right on their host strains of *C. freundii* after an overnight incubation at 37°C**.](fmicb-07-01023-g0002){#F2}

The host range of the five phages was determined using the 31 Gram-negative bacterial strains described in the Materials and Methods section. Phages SH1 and SH2 were able to lyse their host strain, *C. freundii* CF5, and *S.* Typhi HER1038. Phage SH3 was able to lyse its host strain, *C. freundii* CF3 and *C. freundii* CF4. Phages SH4 and SH5 lysed their host strain, *C. freundii* CF3, as well as *C. freundii* CF4 and *C. turicensis* 290708/7.

Sensitivity to pH
-----------------

The five phages were tested for their susceptibility to different pH conditions. They were exposed to pHs ranging from 2 to 10 for 1 h at 37°C. All phages were completely inactivated when exposed to pH 2 and pH 3. A 10-fold reduction in phage titer was also noticed at pH 4. All phage suspensions were stable from pH 5 to pH 10.

Morphological characteristics
-----------------------------

Negatively stained purified phages were observed with an electron microscope and all five possessed an icosahedral capsid and small non-contractile tail (Figure [3](#F3){ref-type="fig"}, Table [3](#T3){ref-type="table"}). However, the tips of the tails differed which led us to divide them into two morphological groups. The first group included phages SH1 and SH2, which had a narrower base plate compared to the second group, which included phages SH3, SH4, and SH5 (Figure [3](#F3){ref-type="fig"}). Nonetheless, their overall morphology allowed us to classify the five phages into the *Caudovirales* order and the *Podoviridae* family.

![**Electron micrographs of phages SH1 (left) and SH3 (right)**.](fmicb-07-01023-g0003){#F3}

###### 

**Morphological and genomic characteristics of the five isolated phages and phage T7**.

  **Phage**                                 **Capsid (nm)**   **Tail (nm)**   **Genome size (bp)**   **GC%**   **Terminal repeat (bp)**   
  ----------------------------------------- ----------------- --------------- ---------------------- --------- -------------------------- -----
  **SH1**                                   61 ± 1.6          14 ± 0.9        12 ± 1.0               39,434    51.0                       230
  **SH2**                                   58 ± 2.5          14 ± 1.4        10 ± 1.1               39,158    50.7                       242
  **SH3**                                   65 ± 1.4          21 ± 1.1        13 ± 1.0               39,444    50.6                       183
  **SH4**                                   67 ± 1.3          29 ± 2.4        16 ± 1.2               39,274    52.6                       190
  **SH5**                                   65 ± 1.1          27 ± 1.8        16 ± 2.0               39,832    52.5                       190
  **T7**[^\*^](#TN1){ref-type="table-fn"}   56                14              9                      39,936    50                         160

According to (Ackermann and Nguyen, [@B2]; Dunn et al., [@B23]).

Genomic characteristics
-----------------------

The double-stranded DNA of the five phages was extracted and sequenced. The genome size of these phages ranged from 39,158 to 39,832 bp, which was similar to that of coliphage T7 (39,936 bp) (Table [3](#T3){ref-type="table"}). The GC contents of the phage genomes were similar to that of their *C. freundii* hosts, 50 to 51% (Frederiksen, [@B27]). After genome alignments with similar phages, primers adjacent to the predicted terminal ends were used to directly sequence the phage genomic DNA. As expected, the sequencing signal dropped at the end of the genome (Figure [4](#F4){ref-type="fig"}) and this was used to determine the position of the terminal ends and their sequences. The last adenine at the end of the repeated sequences was not considered because it is added by the polymerase (Clark, [@B17]; Garneau et al., [@B28]). Our analyses revealed that the five *Podoviridae* phage (podophage) genomes contained direct terminal repeats at both ends (Table [3](#T3){ref-type="table"}). The length of the direct terminal repeats of phages SH1 (230 bp) and SH2 (242 bp) were similar to that of *Yersinia* phage phiYeO3-12 (232 bp; Pajunen et al., [@B56]), *Salmonella* phage phiSG-JL2 (230 bp; Kwon et al., [@B42]), and *Citrobacter* phage phiCFP-1 (229 bp; Zhao et al., [@B78]). Terminal repeat lengths of SH3 (183 bp), SH4 (190 bp), and SH5 (190 bp) were close to the length of coliphage K1F (179 bp; Scholl and Merril, [@B65]).

![**SH5 genome sequencing with both reverse and forward primers**.](fmicb-07-01023-g0004){#F4}

Genome organization
-------------------

Analyses of the predicted *orfs* in the genomes of the five newly isolated podophages revealed that they all have the same transcriptional orientation and use only ATG as an initiation codon (Tables [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}). Comparative genome analyses also indicated that these phages were affiliated with the *Autographivirinae* subfamily and the *T7virus* genus. Similar to the morphological groupings, we could also divide the five phage genomes into subgroups (Figure [5](#F5){ref-type="fig"}). The first group included phages SH1 and SH2, which had high identity (80%) to genes of *Yersinia* phage phiYeO3-12 as well as coliphages T7 and T3. The second phage group (SH3, SH4, and SH5) could be divided into two subgroups. Group 2A included phage SH3, which was close to coliphage K1F, while group 2B was comprised of phages SH4 and SH5, which are similar to *Cronobacter* phage Dev2.

###### 

**Features of the ORFs of phage SH2, identity with SH1, predicted functions of proteins, and best matches with database**.

                                       **Predicted protein**                                                                      **Aligned protein**                                                                                                                          
  ------ ------------- ------- ------- ----------------------- ------- ------ --------------------------------------------------- ----------------------------------------------- ------------------------------------------------------------------------- ----------- ------ ----------------------------------
  1      ORF1, 99      948     1406    152                     17.0    7.6    [T]{.ul}G[AGG]{.ul}TAACaccaa**ATG**                 S-adenosyl-l-methionine hydrolase               gp0.3 \[*Yersinia* phage phiYeO3-12\] (152/152; 100%)                     4.00E-110   152    [NP_052065.1](NP_052065.1)
  2      ORF2, 87      1479    1679    66                      7.5     6.8    AT[AGGA]{.ul}CTAacacc**ATG**                                                                        gp0.45 \[*Salmonella* phage phiSG-JL2\] (65/66; 98%)                      4.00E-41    66     [YP_001949746.1](YP_001949746.1)
  3      ORF3, 74      1699    1857    52                      6.0     9.7    AC[AGGAGG]{.ul}Attagca**ATG**                                                                       hypothetical protein \[*Enterobacter* phage E-4\] (49/52; 94%)            3.00E-26    52     [AKA61646.1](AKA61646.1)
  4      ORF4, 94      1854    2051    65                      7.8     10.5   [T]{.ul}GGT[GA]{.ul}AACacgc**ATG**                                                                  hypothetical protein \[*Enterobacter* phage E-4\] (63/65; 97%)            2.00E-38    65     [AKA61645.1](AKA61645.1)
  5      ORF5, 95      2073    3182    369                     42.3    7.1    [TAAGGA]{.ul}CACactgaa**ATG**                       Protein kinase                                  gp0.7 \[*Yersinia* phage phiYeO3-12\] (346/369; 94%)                      0.0         369    [NP_052070.1](NP_052070.1)
  6      ORF6,99       3253    5907    884                     98.8    7.1    C[AA]{.ul}T[GAGGT]{.ul}aagca**ATG**                 RNA polymerase                                  DNA-directed RNA polymerase \[*Enterobacter* phage E-2\] (881/884; 99%)   0.0         884    [AKA61565.1](AKA61565.1)
  7      ORF7, 90      6008    6502    164                     19.6    9.2    [TAAG]{.ul}AG[G]{.ul}A[T]{.ul}tacttt**ATG**                                                         gp1.05 \[*Salmonella* phage phiSG-JL2\] (76/165; 46%)                     3.00E-38    169    [YP_001949751.1](YP_001949751.1)
  8      ORF8, 100     6593    6733    46                      5.9     10.9   [TAAG]{.ul}ATAC[T]{.ul}**ATG**                                                                      gp1.1 \[*Yersinia* phage phiYeO3-12\] (46/46; 100%)                       2.00E-23    46     [NP_052073.1](NP_052073.1)
  9      ORF9, 69      6736    7008    91                      10.3    7.9    AGT[GGA]{.ul}AC[T]{.ul}aatg**ATG**                  Deoxyguanosine triphospho-hydrolase inhibitor   gp1.2 \[*Salmonella* phage phiSG-JL2\] (90/91; 99%)                       1.00E-160   92     [YP_001949753.1](YP_001949753.1)
  10     ORF10, 98     7103    8119    338                     38.4    5.0    [T]{.ul}G[AGGA]{.ul}ACAaccgt**ATG**                 DNA ligase                                      gp1.3 \[*Salmonella* phage phiSG-JL2\] (333/338; 99%)                     0.0         338    [YP_001949754.1](YP_001949754.1)
  11     ORF11, 94     8291    8548    85                      9.9     11.2   [TAAGGAG]{.ul}ACaacatc**ATG**                       LysR family transcriptional regulator           gp1.6 \[*Yersinia* phage phiYeO3-12\] (85/85; 100%)                       2.00E-53    85     [NP_052078.1](NP_052078.1)
  12     ORF12, 66     8548    9132    194                     21.6    9.1    [TAAGGAGGT]{.ul}gctgta**ATG**                       Nucleotide kinase                               phiYe-F10_00014 \[*Yersinia* phage phiYe-F10\] (163/190; 86%)             6.00E-115   190    [AKQ06773.1](AKQ06773.1)
  13     ORF14, 85     9119    9256    45                      5.3     5.2    [TAAGG]{.ul}G[G]{.ul}C[T]{.ul}gtgct**ATG**                                                          AVU28_gp19 \[*Enterobacter* phage E-3\] (42/45; 93%)                      1.00E-21    45     [AKA61598.1](AKA61598.1)
  14     ORF15, 62     9253    9489    78                      8.8     4.8    [TAAGGAGG]{.ul}Ccaataa**ATG**                       Bacterial RNA polymerase inhibitor              ORF13 \[*Yersinia* phage vB_YenP_AP5\] (77/78; 99%)                       1.00E-50    78     [AIM40358.1](AIM40358.1)
  15     ORF16, 98     9542    10240   232                     26.0    4.8    A[AAGGAG]{.ul}AAacatc**ATG**                        Single-stranded DNA-binding                     phiYe-F10_00017 \[*Yersinia* phage phiYe-F10\] (227/232; 98%)             4.00E-166   232    [AKQ06776.1](AKQ06776.1)
  16     ORF18, 73     10240   10701   153                     17.6    9.5    CG[AGGA]{.ul}CT[T]{.ul}cta**ATG**                   Endonuclease                                    gp3 \[*Yersinia* phage phiYeO3-12\] (152/153; 99%)                        2.00E-105   153    [NP_052083.1](NP_052083.1)
  17     ORF19, 99     10694   11149   151                     16.9    9.0    [TAA]{.ul}A[GA]{.ul}AAA**ATG**                      N-acetylmuramoyl-l-alanine amidase              AVU28_gp15 \[*Enterobacter* phage E-3\] (151/151; 100%)                   2.00E-108   151    [AKA61594.1](AKA61594.1)
  18     ORF20, 100    11154   11261   35                      4.2     8.5    G[A]{.ul}G[GG]{.ul}T[G]{.ul}A[T]{.ul}acc**ATG**                                                     3.7 protein \[*Yersinia* phage phiYeO3-12\] (35/35; 100%)                 2.00E-15    35     [NP_052086.1](NP_052086.1)
  19     ORF21,99      11328   13028   566                     6.3     5.2    [TAAGGA]{.ul}ATGtaca**ATG**                         Primase/Helicase                                gp4A \[*Salmonella* phage phiSG-JL2\] (560/566; 99%)                      0.0         566    [YP_001949764.1](YP_001949764.1)
  19.1   ORF21.1, 94   11362   11517   51                      5.6     6.5    [T]{.ul}CTTTCT[GT]{.ul}ttc**ATG**                                                                   hypothetical protein \[*Enterobacteria* phage T3\] (49/51; 96%)           1.00E-26    51     [AGM10719.1](AGM10719.1)
  19B    ORF21B,99     11514   13028   504                     55.9    5.1    GG[AGG]{.ul}CA[GT]{.ul}aaccct**ATG**                Primase/Helicase                                Primase/Helicase protein \[*Enterobacter* phage E-3\] (501/504; 99%)      0.0         504    [AKA61593.1](AKA61593.1)
  19.2   ORF21.2, 97   12748   13077   109                     12.1    6.7    G[AAGG]{.ul}GAAAaccac**ATG**                                                                        gp4.2 \[*Enterobacteria* phage T3\] (103/109; 94%)                        2.00E-66    109    [NP_523317.1](NP_523317.1)
  20     ORF22, 97     13124   13336   70                      7.7     10.0   AT[AGGAG]{.ul}ACacatc**ATG**                                                                        gp4.3 \[*Yersinia* phage phiYeO3-12\] (68/70; 97%)                        4.00E-29    70     [NP_052091.1](NP_052091.1)
  21     ORF23, 100    13349   13633   94                      10.7    9.9    [TAAGGAG]{.ul}CGaacact**ATG**                                                                       gp4.5 \[*Yersinia* phage phiYeO3-12\] (94/94; 100%)                       2.00E-62    94     [NP_052092.1](NP_052092.1)
  22     ORF24, 98     13701   15815   704                     79.8    6.5    A[AAGGAGG]{.ul}Gcatt**ATG**                         DNA polymerase                                  gp5 \[*Yersinia* phage phiYeO3-12\] (700/704; 99%)                        0.0         704    [NP_052093.1](NP_052093.1)
  23                   15825   16157   110                     13.0    9.5    [TAAGGAGG]{.ul}Attt**ATG**                          Homing Endonuclease                             gp5.3 \[*Yersinia* phage phiYeO3-12\] (110/110; 100%)                     2.00E-75    110    [NP_052095.1](NP_052095.1)
  24     ORF25, 99     16135   16437   101                     11.1    6.3    A[AAGGAG]{.ul}AAacatt**ATG**                        HNS binding                                     gp5.5 \[*Yersinia* phage phiYeO3-12\] (100/101; 99%)                      4.00E-66    101    [NP_052097.1](NP_052097.1)
  25     ORF26, 100    16553   16762   69                      7.3     9.8    [T]{.ul}TG[GGAGGT]{.ul}actcta**ATG**                                                                gp5.7 \[*Yersinia* phage phiYeO3-12\] (69/69; 100%)                       8.00E-42    69     [NP_052098.1](NP_052098.1)
  26     ORF27, 99     16705   16941   60                      8.8     4.2    C[AA]{.ul}T[G]{.ul}GT[G]{.ul}Gagc**ATG**                                                            gp5.9 \[*Yersinia* phage phiYeO3-12\] (60/60; 100%)                       1.00E-34    60     [NP_072071.1](NP_072071.1)
  27     ORF28, 99     16938   17849   303                     34.7    4.9    GG[AGGA]{.ul}T[G]{.ul}Acga**ATG**                   Exonuclease                                     AVU28_gp07 \[*Enterobacter* phage E-3\] (301/303; 99%)                    0.0         303    [AKA61586.1](AKA61586.1)
  28     ORF29, 100    17831   17944   37                      4.1     9.7    C[AAGGAG]{.ul}A[T]{.ul}ttactt**ATG**                                                                gp6.3 \[*Yersinia* phage phiYeO3-12\] (37/37; 100%)                       1.00E-15    37     [NP_052102.1](NP_052102.1)
  29     ORF30, 96     18039   18284   81                      9.3     5.9    [T]{.ul}T[A]{.ul}A[GAGGT]{.ul}gaattt**ATG**                                                         gp6.5 \[*Yersinia* phage phiYeO3-12\] (79/81; 98%)                        4.00E-51    81     [NP_052103.1](NP_052103.1)
  30     ORF31, 69     18289   18540   83                      8.8     9.1    AC[AGGAG]{.ul}TAattat**ATG**                        Head                                            gp6.7 \[*Yersinia* phage vB_YenP_AP5\] (83/83; 100%)                      2.00E-49    83     [YP_009102822.1](YP_009102822.1)
  31     ORF32, 96     18568   18888   106                     11.0    9.8    [TA]{.ul}G[GGAG]{.ul}AAacatc**ATG**                 Host specificity protein B                      gp7.3 \[*Salmonella* phage phiSG-JL2\] (105/106; 99%)                     1.00E-62    106    [YP_001949779.1](YP_001949779.1)
  32     ORF33, 99     18899   20506   535                     58.6    4.5    [TAAGGAGG]{.ul}Actga**ATG**                         Head-to-tail joining                            gp8 \[*Yersinia* phage phiYeO3-12\] (535/535; 100%)                       0.0         535    [NP_052106.1](NP_052106.1)
  33     ORF34, 97     20608   21540   310                     33.8    4.3    [T]{.ul}T[AGGAG]{.ul}A[T]{.ul}ttaaca**ATG**         Capsid assembly                                 ORF30 \[*Citrobacter* phage phiCFP-1\] (303/310; 98%)                     0.0         310    [AKA62148.1](AKA62148.1)
  34     ORF35, 95     21697   22740   347                     36.8    6.2    [TAAGGAG]{.ul}A[T]{.ul}tcaac**ATG**                 Minor and Major capsid                          10A \[*Yersinia* phage phiYe-F10\] (344/346; 99%)                         0.0         347    [AKQ06793.1](AKQ06793.1)
  35                   22779   23012   77                      7.4     4.5    [T]{.ul}C[AG]{.ul}AA[G]{.ul}ACt**ATG**              Minor capsid                                    AVU28_gp35 \[*Enterobacter* phage E-3\] (73/77; 95%)                      1.00E-39    77     [AKA61614.1](AKA61614.1)
  36     ORF36, 99     23125   23715   196                     22.2    4.5    AC[AGGAGGT]{.ul}aacatc**ATG**                       Tail tubular A                                  gp11 \[*Yersinia* phage phiYeO3-12\] (196/196; 100%)                      1.00E-141   196    [NP_052110.1](NP_052110.1)
  37     ORF37, 99     23731   26136   801                     89.8    5.9    C[AAGGAGG]{.ul}Ctct**ATG**                          Tail tubular B                                  gp12 \[*Salmonella* phage phiSG-JL2\] (797/801; 99%)                      0.0         801    [YP_001949785.1](YP_001949785.1)
  38     ORF38, 98     26209   26619   136                     15.8    5.6    [TAA]{.ul}A[G]{.ul}CAT[T]{.ul}**ATG**               Internal virion A                               AXI78_gp37 \[*Enterobacter* phage E-2\] (134/136; 99%)                    4.00E-95    136    [AKA61575.1](AKA61575.1)
  39     ORF39, 100    26622   27215   197                     21.2    9.4    GT[AGGAGGT]{.ul}aact**ATG**                         Internal virion B                               gp14 \[*Yersinia* phage phiYeO3-12\] (194/197; 98%)                       4.00E-136   197    [NP_052114.1](NP_052114.1)
  40     ORF40, 80     27218   29461   747                     84.6    6.1    CCG[GGAGGT]{.ul}aata**ATG**                         Internal virion C                               ORF37 \[*Citrobacter* phage phiCFP-1\] (711/747; 95%)                     0.0         747    [AKA62155.1](AKA62155.1)
  41     ORF41, 83     29484   33452   1322                    144.2   6.7    [TAAGGAGG]{.ul}Ctcc**ATG**                          Internal virion D                               ORF38 \[*Citrobacter* phage phiCFP-1\] (1296/1322; 98%)                   0.0         1322   [AKA62156.1](AKA62156.1)
  42     ORF42, 92     33524   35500   658                     69.9    6.0    A[AAGGAGGT]{.ul}cac**ATG**                          Tail fiber                                      gp17 \[*Salmonella* phage phiSG-JL2\] (593/658; 90%)                      0.0         658    [YP_001949790.1](YP_001949790.1)
  43     ORF43, 99     35511   35714   67                      7.4     6.1    [TAAGGAGG]{.ul}Acata**ATG**                         Lysis                                           gp17.5 \[*Yersinia* phage phiYeO3-12\] (66/67; 99%)                       5.00E-39    67     [NP_052118.1](NP_052118.1)
  44     ORF44, 100    35718   35984   88                      9.9     4.7    C[AAGGAG]{.ul}TAacct**ATG**                         DNA packaging A                                 gp18 \[*Salmonella* phage phiSG-JL2\] (88/88; 100%)                       1.00E-55    88     [YP_001949792.1](YP_001949792.1)
  45     ORF45, 99     36062   36526   150                     17.3    9.2    ATG[GGAGGT]{.ul}gtt**ATG**                          Endopeptidase Rz                                ORF42 \[*Citrobacter* phage phiCFP-1\] (152/154; 99%)                     1.00E-107   154    [AKA62160.1](AKA62160.1)
  45.7   ORF45.7, 99   36189   36443   84                      9.3     9.8    [TAA]{.ul}TCCAAA**ATG**                                                                             gp18.7 \[*Salmonella* phage phiSG-JL2\] (83/84; 99%)                      9.00E-52    84     [YP_001949794.1](YP_001949794.1)
  46     ORF46, 99     36501   38264   587                     66.6    5.3    [TAAGGAG]{.ul}A[T]{.ul}gcaga**ATG**                 DNA packaging B                                 gp19 \[*Salmonella* phage phiSG-JL2\] (581/587; 99%)                      0.0         587    [YP_001949795.1](YP_001949795.1)
  46.2   ORF46.2, 93   37213   37383   56                      6.1     10.0   G[AAG]{.ul}ACTTGtact**ATG**                                                                         19.2 protein \[*Yersinia* phage phiYeO3-12\] (56/56; 100%)                2.00E-28    77     [NP_052123.1](NP_052123.1)
  46.3   ORF46.3, 95   37687   37815   42                      4.7     11.9   [T]{.ul}GGC[G]{.ul}G[G]{.ul}T[T]{.ul}ccgcg**ATG**                                                   19.3 protein \[*Yersinia* phage phiYeO3-12\] (42/42; 100%)                1.00E-19    42     [NP_052124.1](NP_052124.1)
  47     ORF47, 96     38509   38658   49                      5.5     7.9    A[AAGGAGGT]{.ul}ggctcA**ATG**                                                                       AVU28_gp23 \[*Enterobacter* phage E-3\] (48/49; 98%)                      9.00E-25    49     [AKA61602.1](AKA61602.1)

Start codon indicated in boldface; Match to SD sequence is indicated by underlining; SD position is indicated in uppercase.

The number of identical amino acids/The total number of amino acids of smallest protein.

###### 

**Features of the ORFs of phage SH5, identity with SH4 and SH3, predicted functions of proteins, and best matches with database**.

                                                      **Predicted protein**                                                                  **Aligned protein**                                                                                                          
  ------ -------------- ------------- ------- ------- ----------------------- ------- ------ ----------------------------------------------- ------------------------------------ -------------------------------------------------------------------- ----------- ------ ----------------------------------
  1      ORF1, 100                    934     1137    68                      7.9     6.1    AT[AGGA]{.ul}TAAacaag**ATG**                                                         metaG-MbCM1_078 \[*Synechococcus* phage metaG-MbCM1\] (28/59; 47%)   3.00E-11    59     [YP_007001569.1](YP_007001569.1)
  2      ORF2, 100                    1134    1658    175                     20.2    5.7    [TAAGGA]{.ul}AC[T]{.ul}acaatc**ATG**                                                 CPT_Seurat66 \[*Escherichia* phage Seurat\](87/167; 52%)             6.00E-48    167    [YP_009152010.1](YP_009152010.1)
  3      ORF3, 100      ORF3, 84      1652    1807    52                      5.9     9.4    AGGT[GAGGT]{.ul}catcaag**ATG**                                                       gp0.35 \[*Enterobacteria* phage EcoDS1\] (47/50; 94%)                2.00E-27    50     [YP_002003737.1](YP_002003737.1)
  4      ORF4, 100                    2006    2173    56                      5.9     8.3    AT[AGGAG]{.ul}T[T]{.ul}aact**ATG**                                                   PE3_004 \[*Escherichia* phage PE3-1\] (48/55; 87%)                   2.00E-24    55     [YP_009044252.1](YP_009044252.1)
  5      ORF5, 100      ORF5, 99      2177    2374    66                      7.5     11.0   GCG[GGA]{.ul}TAAacc**ATG**                                                           gp0.6 \[*Enterobacteria* phage EcoDS1\](64/65; 98%)                  4.00E-37    65     [YP_002003739.1](YP_002003739.1)
  6      ORF6, 100      ORF6, 56      2374    2700    108                     12.1    9.3    [T]{.ul}TG[GGAG]{.ul}CAaactgta**ATG**                                                PE3_006 \[*Escherichia* phage PE3-1\] (76/108; 70%)                  8.00E-48    130    [YP_009044254.1](YP_009044254.1)
  7      ORF7, 100      ORF7, 93      2798    5479    894                     100.5   7.6    C[AAGGA]{.ul}CT[T]{.ul}taagt**ATG**             RNA polymerase                       gp1 \[*Cronobacter* phage Dev2\] (883/893; 99%)                      0.0         893    [YP_009005115.1](YP_009005115.1)
  8      ORF8, 100      ORF8, 78      5492    5692    67                      7.3     9.7    [TAAGGAGG]{.ul}Catctac**ATG**                                                        gp1.1 \[*Cronobacter* phage Dev2\] (66/66; 100%)                     6.00E-38    66     [YP_009005116.1](YP_009005116.1)
  9      ORF9, 100                    5771    6250    160                     18.6    9.3    AG[AGG]{.ul}TT[G]{.ul}Acact**ATG**                                                   gp1.06 \[*Cronobacter* phage Dev2\](155/159; 97%)                    1.00E-110   159    [YP_009005117.1](YP_009005117.1)
  10     ORF10, 100     ORF10, 98     6339    6518    60                      6.8     10.2   ACT[GGAG]{.ul}A[T]{.ul}ttaacc**ATG**                                                 gp1.15 \[*Cronobacter* phage Dev2\](58/59; 98%)                      4.00E-33    59     [YP_009005118.1](YP_009005118.1)
  11     ORF11, 100     ORF11, 22     6522    6809    96                      11.2    6.3    GT[AGGAG]{.ul}CGtaagac**ATG**                                                        PE3_010 \[*Escherichia* phage PE3-1\](81/95; 85%)                    5.00E-56    95     [YP_009044258.1](YP_009044258.1)
  12     ORF12, 99      ORF12, 75     6827    7897    357                     40.2    5.5    [T]{.ul}CT[GGAG]{.ul}ACattaacg**ATG**           DNA ligase                           gp1.3 \[*Enterobacteria* phage EcoDS1\] (318/357; 89%)               0.0         365    [YP_002003747.1](YP_002003747.1)
  13     ORF13, 100     ORF13, 49     8019    8273    85                      9.85    9.9    AG[AGGAG]{.ul}AAacctt**ATG**                                                         gp1.6 \[*Enterobacteria* phage EcoDS1\] (73/84; 87%)                 6.00E-47    84     [YP_002003748.1](YP_002003748.1)
  14     ORF14, 100     ORF14, 67     8273    8593    107                     12.2    6.9    C[AAGGAGG]{.ul}Agttcta**ATG**                                                        gp1.7 \[*Cronobacter* phage Dev2\] (85/107; 79%)                     5.00E-50    116    [YP_009005122.1](YP_009005122.1)
  15     ORF15, 100     ORF16, 65     8672    8887    72                      8.2     4.5    G[AAGGAG]{.ul}AAaggact**ATG**                   Bacterial RNA polymerase inhibitor   gp2 \[*Cronobacter* phage Dev2\] (48/54; 89%)                        3.00E-25    54     [YP_009005123.1](YP_009005123.1)
  16     ORF16, 100     ORF17, 85     8935    9633    233                     25.4    4.8    CT[AGGAG]{.ul}A[T]{.ul}ttacaccg**ATG**          Helix-destabilizing protein          gp2.5 \[*Cronobacter* phage Dev2\] (229/232; 99%)                    2.00E-164   232    [YP_009005124.1](YP_009005124.1)
  17     ORF17, 100     ORF18, 43     9870    10088   72                      8.3     9.9    [TAAG]{.ul}A[AG]{.ul}CAt**ATG**                 Endonuclease                         gp3 \[*Cronobacter* phage Dev2\] (72/72; 100%)                       2.00E-44    139    [YP_009005125.1](YP_009005125.1)
  18     ORF18, 100     ORF19, 81     10085   10309   75                      8.6     9.7    A[AAGGAG]{.ul}C[T]{.ul}aagaa**ATG**                                                  gp3.2 \[*Cronobacter* phage Dev2\] (74/74; 100%)                     3.00E-45    74     [YP_009005126.1](YP_009005126.1)
  19     ORF19, 98      ORF20, 90     10299   10757   153                     16.9    8.8    GCT[GG]{.ul}T[GGT]{.ul}gtaca**ATG**             N-acetylmuramoyl-l-alanine amidase   gp3.5 \[*Cronobacter* phage Dev2\] (152/152; 100%)                   8.00E-109   152    [YP_009005127.1](YP_009005127.1)
  20     ORF20, 100     ORF21, 61     10772   10984   71                      7.4     10.1   C[AAGGAG]{.ul}TAttaac**ATG**                                                         gp3.7 \[*Cronobacter* phage Dev2\] (69/70; 99%)                      1.00E-28    70     [YP_009005128.1](YP_009005128.1)
  21                                  11142   11507   122                     13.9    10.1   GCG[GGA]{.ul}TAAacc**ATG**                      HNH endonuclease                     gp3.8 \[*Enterobacteria* phage T7\] (65/121; 54%)                    1.00E-40    121    [NP_041974.1](NP_041974.1)
  22     ORF21, 97      ORF22, 90     11482   13179   566                     62.2    5.1    [TAAGGAGG]{.ul}Ctc**ATG**                       Primase/Helicase                     gp4 \[*Cronobacter* phage Dev2\] (545/566; 96%)                      0.0         567    [YP_009005129.1](YP_009005129.1)
  22B    ORF21B, 98     ORF22B, 92    11782   13179   465                     51.3    5.2    [T]{.ul}TG[GG]{.ul}TA[G]{.ul}Gc**ATG**          Primase/Helicase                     gp4 \[Cronobacter phage Dev2\] (475/465; 98%)                        0.0         567    [YP_009005129.1](YP_009005129.1)
  22.2   ORF21.2, 61    ORF22.2, 62   12908   13255   115                     13.0    9.0    A[AAGG]{.ul}TAAGtctc**ATG**                                                          gp4.2 \[Enterobacteria phage K1F\] (63/107; 56%)                     2.00E-25    107    [CAJ29367.1](CAJ29367.1)
  23     ORF22, 66      ORF23, 69     13182   13766   194                     21.2    4.7    C[AA]{.ul}C[GA]{.ul}CT[T]{.ul}ctgacc**ATG**                                          gp4.1 \[*Cronobacter* phage Dev2\] (168/177; 95%)                    1.00E-117   177    [YP_009005130.1](YP_009005130.1)
  24     ORF23, 99      ORF24, 90     13837   16008   724                     80.9    7.0    AT[AGGAG]{.ul}ACatt**ATG**                      DNA polymerase                       gp5 \[*Cronobacter* phage Dev2\] (717/723; 99%)                      0.0         723    [YP_009005131.1](YP_009005131.1)
  25     ORF24, 97      ORF26, 96     16008   16292   95                      10.5    5.2    G[AAGGAG]{.ul}TGtcacta**ATG**                   HNS binding protein                  gp5.5 \[*Cronobacter* phage Dev2\] (92/94; 98%)                      4.00E-58    94     [YP_009005133.1](YP_009005133.1)
  26     ORF25, 100     ORF27, 100    16289   16498   70                      7.4     9.0    ATTC[GAGGT]{.ul}caaacg**ATG**                                                        gp21 \[*Enterobacteria* phage K1F\] (69/69; 100%)                    5.00E-43    69     [YP_338112.1](YP_338112.1)
  27     ORF26, 100                   16495   16770   92                      9.9     5.3    GG[AGG]{.ul}CT[GT]{.ul}ct**ATG**                                                     ASC_0027 \[*Klebsiella* phage K11\](37/68; 54%)                      2.00E-19    68     [YP_002003815.1](YP_002003815.1)
  28     ORF27, 99      ORF28, 90     16763   17629   289                     32.9    5.4    A[AAGGAGGT]{.ul}ctgcggg**ATG**                  Exonuclease                          gp6 \[*Cronobacter* phage Dev2\] (284/288; 99%)                      0.0         288    [YP_009005135.1](YP_009005135.1)
  29     ORF28, 100     ORF29, 56     17837   18109   91                      9.9     5.2    AG[AGGAG]{.ul}ACtttaag**ATG**                                                        gp6.5 \[*Cronobacter* phage Dev2\] (90/90; 100%)                     8.00E-58    90     [YP_009005136.1](YP_009005136.1)
  30     ORF29, 100     ORF30, 92     18120   18344   75                      7.6     6.2    A[AAGGAGG]{.ul}Gact**ATG**                      Head protein                         gp6.7 \[*Cronobacter* phage Dev2\] (74/74; 100%)                     1.00E-42    74     [YP_009005137.1](YP_009005137.1)
  31     ORF30, 100     ORF31, 91     18348   18752   135                     15.5    6.1    AC[A]{.ul}T[G]{.ul}G[GGT]{.ul}AAGac**ATG**                                           gp34 \[*Citrobacter* phage CR44b\] (127/135; 94%)                    7.00E-89    185    [YP_009007168.1](YP_009007168.1)
  32     ORF31, 100     ORF32, 96     19011   20579   523                     57.2    4.6    GC[AGGAGGT]{.ul}gacaa**ATG**                    Head to tail connector protein       gp8 \[*Cronobacter* phage Dev2\] (522/522; 100%)                     0.0         522    [YP_009005140.1](YP_009005140.1)
  33     ORF32, 99      ORF33, 81     20684   21565   294                     31.7    4.4    A[AAGGAG]{.ul}AAcgactca**ATG**                  Capsid assembly protein              gp9 \[*Cronobacter* phage Dev2\] (290/293; 99%)                      0.0         293    [YP_009005141.1](YP_009005141.1)
  34     ORF33, 99      ORF34, 94     21697   22746   350                     36.4    5.8    AT[AGGAG]{.ul}AAttatcat**ATG**                  Major capsid protein                 gp10 \[*Cronobacter* phage Dev2\] (347/349; 99%)                     0.0         349    [YP_009005142.1](YP_009005142.1)
  35     ORF34, 100     ORF35, 97     23067   23633   189                     21.3    4.4    [TAAGGAGG]{.ul}Gcct**ATG**                      Tail tube protein A                  gp11 \[*Cronobacter* phage Dev2\] (187/188; 99%)                     3.00E-135   188    [YP_009005144.1](YP_009005144.1)
  36     ORF35, 99      ORF36, 87     23645   26014   790                     87.6    5.8    AT[AGGAGGT]{.ul}gat**ATG**                      Tail tube protein B                  gp12 \[*Cronobacter* phage Dev2\] (779/789; 99%)                     0.0         789    [YP_009005145.1](YP_009005145.1)
  37     ORF36, 97      ORF37, 83     26090   26548   153                     17.5    6.9    AT[AGGAG]{.ul}ACttt**ATG**                      Internal virion protein A            gp13 \[*Cronobacter* phage Dev2\] (150/152; 99%)                     6.00E-107   152    [YP_009005146.1](YP_009005146.1)
  38     ORF37, 98      ORF38, 91     26669   27256   196                     20.4    6.8    CCG[GGAGGT]{.ul}gaaag**ATG**                    Internal virion protein B            gp14 \[*Cronobacter* phage Dev2\] (194/195; 99%)                     1.00E-136   195    [YP_009005147.1](YP_009005147.1)
  39     ORF38, 99      ORF39, 89     27268   29550   761                     85.3    5.5    AT[AGGAGG]{.ul}Acca**ATG**                      Internal virion protein C            gp15 \[*Cronobacter* phage Dev2\] (749/760; 99%)                     0.0         760    [YP_009005148.1](YP_009005148.1)
  40     ORF39, 99      ORF40, 92     29556   33452   1299                    141.0   5.8    [TAAGGAG]{.ul}TAataaca**ATG**                   Internal virion protein D            gp16 \[*Cronobacter* phage Dev2\] (1282/1298; 99%)                   0.0         1298   [YP_009005149.1](YP_009005149.1)
  41     ORF40, 100     ORF41, 79     33520   36018   832                     91.3    6.4    [TAAGGAGG]{.ul}Ccca**ATG**                      Tail fibers                          gp17 \[*Cronobacter* phage Dev2\] (805/832; 97%)                     0.0         832    [YP_009005150.1](YP_009005150.1)
  42     ORF41, 100     ORF42, 95     36065   36259   65                      6.9     8.0    A[A]{.ul}C[GGAGGT]{.ul}att**ATG**               Lysis protein                        gp17.5 \[*Cronobacter* phage Dev2\] (64/64; 100%)                    4.00E-37    64     [YP_009005151.1](YP_009005151.1)
  43     ORF42, 100     ORF43, 97     36256   36519   87                      10.1    4.8    AGT[GGAGGT]{.ul}aagac**ATG**                    DNA packaging protein                gp18 \[*Cronobacter* phage Dev2\] (87/87; 100%)                      1.00E-54    87     [YP_009005152.1](YP_009005152.1)
  44     ORF43, 100     ORF44, 73     36624   37073   150                     16.9    8.8    CG[AGGAGG]{.ul}Gcaact**ATG**                    Endopeptidase Rz                     gp18.5 \[*Cronobacter* phage Dev2\] (147/149; 99%)                   3.00E-101   149    [YP_009005153.1](YP_009005153.1)
  44.7   ORF43.7, 100   ORF44.7, 72   36727   36999   90                      9.8     9.6    G[AAGG]{.ul}TAAGca**ATG**                       Endopeptidase Rz1                    gp18.7 \[Enterobacteria phage EcoDS1\] (60/89; 67%)                  2.00E-31    91     [YP_002003785.1](YP_002003785.1)
  45     ORF44, 100     ORF45, 94     37103   38833   577                     65.1    5.3    [T]{.ul}C[AGG]{.ul}C[G]{.ul}C[T]{.ul}t**ATG**   Maturation protein                   gp19 \[*Cronobacter* phage Dev2\] (574/577; 99%)                     0.0         587    [YP_009005154.1](YP_009005154.1)
  45.2   ORF44.2, 100                 37752   37877   41                      4.8     12.1   [TA]{.ul}TCCTC[GT]{.ul}g**ATG**                                                      gp19.2 \[*Enterobacteria* phage K1F\] (27/55; 49%)                   7.00E-09    55     [CAJ29396.1](CAJ29396.1)
  46     ORF45, 100     ORF46, 94     39124   39282   53                      5.5     9.3    G[TA]{.ul}T[G]{.ul}TA[GC]{.ul}**ATG**                                                gp19.5 \[*Cronobacter* phage Dev2\] (52/52; 100%)                    2.00E-27    52     [YP_009005155.1](YP_009005155.1)

Start codon indicated in boldface; Match to SD sequence is indicated by underlining; SD position is indicated in uppercase.

^b^The number of identical amino acids/The total number of amino acids of smallest protein.

![**Schematic representation of the genomic organization of phage T7 (NC_001604.1) compared to phages SH1, SH2, phiYeO3-12 (NC_001271.1), K1F (NC_007456.1), SH3, SH4, SH5, and Dev2 (NC_023558.1)**. Each arrow represents an ORF. Deduced ORFs sharing 95% amino acid identity are represented with the same color. Gray shading indicates ORFs whose translated products share 80% identity with the ones of phage T7. Finally, arrows with thick outlines and bold numbers represent structural proteins detected by LC-MS/MS.](fmicb-07-01023-g0005){#F5}

The genomes of the five isolated phages are co-linear and share the same genomic organization as phage T7 with what seems to be early-, middle-, and late-expressed regions. The early genes are usually involved in host takeover and conversion of the host metabolism for the benefit of phage production (Pajunen et al., [@B56]). This region is also characterized by the presence of an RNA polymerase responsible for the transcription of all the middle- and late-expressed genes. The middle-expressed region includes genes responsible for DNA metabolism while the late region contains genes coding for structural proteins.

Proteomic analyses
------------------

The structural proteome of one phage representing each of the three subgroups (phage SH1 for group 1, SH3 for group 2A and SH4 for group 2B) was analyzed. Purified phages were analyzed by LC-MS/MS and the results are presented in Table [6](#T6){ref-type="table"}. For phage SH1, 11 proteins were detected with an amino acid coverage ranging from 12 to 65%. Ten of the 11 genes coding for these proteins were located in the presumably late-expressed module, as expected for genes coding for structural proteins. The other protein (ORF19) was a N-acetylmuramoyl-L-alanine amidase probably involved in host lysis and it had the lowest coverage (12%). Its gene was located in the middle-expressed region. It is unclear if this protein is in the phage structure or if it is a non-structural phage protein that was carried over from the phage purification process.

###### 

**Identified peptides for phages SH1, SH3 and SH4 and their predicted functions**.

  **Phage**   **Start**   **Stop**   **ORF**   **Predicted function**               **Mass (kDa)**   **Exclusive unique peptide**   **Coverage (%)**
  ----------- ----------- ---------- --------- ------------------------------------ ---------------- ------------------------------ ------------------
  SH1         11614       12069      19        N-acetylmuramoyl-L-alanine amidase   17               2                              12
              18713       19039      31        Capsid protein                       12               2                              36
              19067       19387      32        Host specficity protein B            11               3                              29
              19398       21005      33        Capsid to tail joining protein       59               29                             65
              22196       23236      35        Major capsid protein                 37               22                             60
              23426       24016      36        Tail tubular protein A               22               5                              23
              24032       26437      37        Tail tubular protein B               90               32                             44
              26923       27516      39        Internal virion protein B            21               12                             65
              27519       29762      40        Internal virion protein C            85               36                             59
              29781       33743      41        Internal virion protein D            144              63                             57
              33815       35791      42        Tail fibers protein                  70               21                             48
  SH3         18963       20531      32        Capsid to tail connector protein     57               26                             67
              20676       21560      33        Capsid assembly protein              32               7                              21
              21687       22730      34        Major capsid protein                 36               8                              50
              22925       23491      35        Tail tube protein A                  21               5                              32
              23503       25872      36        Tail tube protein B                  88               24                             37
              26404       26991      38        Internal virion protein B            20               10                             65
              27003       29285      39        Internal virion protein C            85               25                             42
              29290       33177      40        Internal virion protein D            141              45                             45
              33243       35747      41        Tail fibers protein                  91               20                             33
  SH4         18577       20145      31        Capsid to tail connector protein     57               5                              39
              21263       22312      33        Major capsid protein                 36               15                             40
              23211       25580      35        Tail tube protein B                  88               10                             24
              26111       26698      37        Internal virion protein B            20               2                              32
              26710       28992      38        Internal virion protein C            85               14                             29
              28998       32894      39        Internal virion protein D            141              14                             20
              32962       35460      40        Tail fibers protein                  91               9                              18

For phage SH3, 9 structural proteins were detected with coverage ranging from 21 to 67%, while for phage SH4, 7 structural proteins were identified with coverage ranging from 18 to 40%. For these two phages, all the proteins detected were structural proteins from the capsid, head-tail joining, tail, tail tube, and tail fibers.

DNA polymerase phylogeny
------------------------

Because the five *Citrobacter* podophages belong to the *T7virus* genus, we compared in greater detail their relationships with other characterized similar phages available in public database (Figure [6](#F6){ref-type="fig"}). The T7 DNA polymerase is a conserved protein often used to study the global distribution and diversity of podophages, in a manner analogous to the 16S rRNA in bacteria (Breitbart et al., [@B9]). Based on DNA polymerase phylogeny, the five phages were confirmed to belong to the *T7virus* genus in the subfamily *Autographivirinae*. However, they mapped at two different sub-branches. Phages SH1 and SH2 were similar to *Yersinia* phages phiYeO3-12 and vBYenP AP5, *Salmonella* phage phiSG-JL2, *Citrobacter* phage phiCFP-1, and *Enterobacter* phages E3 and E4. They were also closer to the prototype phage T7 than the other three phages characterized here. Phages SH3, SH4, and SH5 were part of the same clade of t7viruses as SH1 and SH2, but clustered in different subgroups. Phage SH3 was related to *Enterobacteria* phages K1F and EcoDS1, and *Escherichia* phage PE3-1. Phages SH4 and SH5 were more related to *Cronobacter* phage Dev2. Taken altogether, despite the differences between these two groupings, SH1/SH2 and SH3/SH4/SH5 seem to be derived from a common ancestor.

![**Phylogenetic relationship between selected phage DNA polymerase sequences**.](fmicb-07-01023-g0006){#F6}

Comparison between phages SH1/SH2, phiYeO3-12, and coliphage T7 (Group 1)
-------------------------------------------------------------------------

Pairwise analyses between the deduced proteomes of phages SH1 and SH2 revealed 31 proteins (out of 53) with more than 95% identity (Table [4](#T4){ref-type="table"}). Among them, seven (ORF8, ORF18, ORF23, ORF26, ORF29, ORF39, ORF44) were 100% identical, including two proteins with predicted functions, ORF39/internal virion protein B and ORF44/DNA packaging protein A. Phage SH1 also shared more than 95% identity with 31 proteins of *Yersinia* phage phiYeO3-12 including seven proteins with 100% identity (ORF8, ORF20, ORF22, ORF23, ORF25, ORF26, ORF29). Phage SH2 shared more than 95% identity with 34 proteins of *Yersinia* phage phiYeO3-12 including 13 proteins with 100% identity (Table [4](#T4){ref-type="table"}). Phage SH2 seems more related to phage phiYeO3-12 than phage SH1. One of the most notable differences between phages SH1 and SH2/phiYeO3-12 was mobile elements. Phage SH1 is missing the homing endonuclease encoded on phages SH2 and phiYeO3-12 (ORF23^SH2^/ORF5.3 ^phiYeO3-12^). However, phage SH1 has another homing endonuclease (ORF17), which is absent in both genomes of SH2 and phiYeO3-12. ORF17^SH1^ is homologous to a homing endonuclease found on *C. rodentium* phage CR44b (46%). Phage SH1 is also missing ORF35^SH2^/ORF10B^phiYeO3-12^ a minor capsid protein (Condron et al., [@B18]). On the other hand, the tail fiber protein of phage phiYeO3-12 shares only 68 and 67% identity with the tail fiber proteins of SH2 and SH1, respectively, which could explain the divergent host ranges between SH1/SH2 and phiYeO3-12. In fact, phages SH1 and SH2 were not able to infect the host strain *Yersinia enterocolitica* 6471/76-c (HER1249) of phage phiYeO3-12.

In addition, phages SH1 and SH2 shared 11 proteins with more than 80% amino acid identity with coliphage T7, including the RNA polymerase (ORF1^T7^ and ORF6^SH1/SH2^). The T7 RNA polymerase initiates transcription by exclusively recognizing its own promoters to ensure fast and efficient transcription of phage DNA. It is also involved in DNA replication, maturation and packaging (Studier and Moffatt, [@B74]; Zhang and Studier, [@B77]).

Another T7 protein homologous to SH1/SH2 proteins was ORF2.5^T7^ (homologous to ORF16^SH1^ and ORF15^SH2^), which is a single-stranded DNA binding protein. The *orf2.5*^*T*7^ gene is essential for phage DNA replication and recombination (Scaltriti et al., [@B64], [@B63]). The N-acetylmuramoyl-L-alanine amidase ORF3.5^T7^ was also related to ORF19^SH1^ and ORF17^SH2^. This lysozyme is involved in cell lysis but may also inhibit transcription by binding to the RNA polymerase to ensure a controlled burst of late transcription (Inouye et al., [@B35]; Moffatt and Studier, [@B53]). ORF21^SH1^ and ORF19^SH2^ were similar to the T7 primase/helicase, ORF4^T7^. This primase/helicase activity is essential for DNA replication (Rosenberg et al., [@B58]) as the helicase catalyzes strand displacement during DNA replication while the primase is involved in the synthesis of the DNA lagging-strand (Mendelman et al., [@B51]).

The ORF5.7 protein of phage T7 shared a high level of identity with ORF26^SH1^ and ORF25^SH2^. ORF5.7 stimulates the expression of gene 5.5 which encodes a H-NS binding protein (Zhu et al., [@B79]). When gene 5.5 is missing, the phage plaque and the burst sizes are reduced (Owen-Hughes et al., [@B55]; Liu and Richardson, [@B47]). The H-NS binding protein inhibits the function of the highly conserved host histone-like nucleoid structuring (H-NS) protein, which influences gene expression, recombination and transcription.

A notable difference between phage T7 and phages SH1/SH2 was in their antirestriction proteins (gp0.3^T7^/ORF1^SH1/SH2^). Restriction-modification (R-M) systems are well-known resistance mechanisms used by bacteria to block phage replication (Labrie et al., [@B44]). Phages also have several means to bypass these systems (Samson et al., [@B62]). The Phage T7Ocr ([o]{.ul}vercoming [c]{.ul}lassical [r]{.ul}estriction, ORF0.3) protein mimics the DNA phosphate backbone, interacting directly with the type R-M*Eco*KI enzyme, and interfering with the activity of this system (Atanasiu et al., [@B6]; Stephanou et al., [@B73]). At the same genomic location (Figure [5](#F5){ref-type="fig"}), the phage SH1 and SH2 *orf1* genes code for a putative S-adenosyl-l-methionine hydrolase, homologous to gp0.3^phiYeO3-12^, which destroys *S*-adenosyl-l-methionine, an essential R--M cofactor (Studier and Movva, [@B75]). The Ocr protein of phage T7 does not have the hydrolase activity. However, the Ocr protein of *E. coli* podophage T3, whose gene is located at the same genomic position, possesses this hydrolase activity.

Comparison between phages SH3 and K1F (Group 2A)
------------------------------------------------

The deduced proteome of phage SH3 (49 ORFs) ranged from 30 to 75% identity to the proteins of phages SH1 and SH2. However, phage SH3 had eight proteins with more than 95% identity to proteins of phages SH4 and SH5, including 100% identity between ORF27^SH3^ and ORF25^SH4^/ORF26^SH5^ (Table [5](#T5){ref-type="table"}). Otherwise, the closest phage to SH3 was coliphage K1F with 23 proteins sharing more than 95% identity. Of these, four proteins are 100% identical, including two with a known function (lysis protein and DNA packaging protein). Genetic differences were noted between *Citrobacter* phage SH3 and *E. coli* phage K1F and the most important difference lies in tail fibers (Gp17^K1F^/ORF41^SH3^) that consist of two domains. The N-terminal domain is responsible for attachment to the phage tail and the C-terminal domain is involved in the recognition of and adsorption to the host LPS (Kajsík et al., [@B37]). The N-terminal parts of the tail fibers of both K1F and SH3 shared a region with the phage T7 tail fiber. However, the central catalytic portion of Gp17^K1F^ encodes an endosialidase to penetrate the host polysaccharide capsule (Scholl and Merril, [@B65]) while ORF41^SH3^ contains a domain of the SGNH hydrolase superfamily like the tail fibers of phages Dev2, SH4, and SH5. However, the C-terminal part of ORF41^SH3^ is different than the tail fibers of phages SH4, SH5, and Dev2, which explains its different host range. The SH3 genome is also missing the putative group I intron present within the DNA polymerase of K1F (gp5.3) which encodes a homing endonuclease.

Comparison between phages SH4/SH5 and Dev2 (Group 2B)
-----------------------------------------------------

Of the 45 genes of phage SH5, 33 were 100% identical to genes of phage SH4. Ten of these genes are also 100% identical to the *T7virus Cronobacter* phage Dev2 genes. These conserved genes suggest that the three phages may be derived from a common ancestor. In addition, phages SH4 and SH5 have more than 95% aa identity with almost all of the phage Dev2 structural proteins. Interestingly, the putative tail fiber proteins ORF40^SH4^ and ORF41^SH5^ were 99% identical to tail fiber gp17 of phage Dev2, suggesting a similar host range. We received phage Dev2 and tested its host range in parallel with phages SH4 and SH5 on the 31 bacterial strains available. The three phages were able to lyse the same strains, *C. freundii* CF3, *C. freundii* CF4, and *C. turicensis* 290708/07.

Phages SH4 and SH5 are missing the genes coding for gp5.1- and gp10.1-like located in the late-expressed region, found in Dev2 (Kajsík et al., [@B37]). Most genomic differences between SH4/SH5 and Dev2 were located in the early-expressed region. ORF21 of phage SH5, which encodes an HNH endonuclease with a zinc-binding motif involved in different steps of phage development (Anba et al., [@B4]), was missing from phages SH4 and Dev2. However, ORF21 shares 54% identity with T7 gp3.8.

The SH4 and SH5 proteins with the lowest similarity were ORF22^SH4^ (132 aa) and ORF23^SH5^ (194 aa) but these were still 66% identical. Their amino acid sequences could be aligned perfectly at the C-terminal end but ORF22^SH4^ is missing the N-terminal portion of ORF23^SH5^. A mutation may have occurred as we noticed the lack of a T base at the ATG codon of ORF22^SH4^. ORF23^SH5^ had 95% identity to gp4.1 of phage Dev2 but its function is unknown.

Discussion {#s4}
==========

In this study, we isolated and characterized five virulent *Podoviridae* phages infecting *C. freundii*, an emerging pathogenic bacterial species (Samonis et al., [@B61]). Genome analyses showed that the five newly isolated phages belong to the *Autographivirinae* subfamily and the *T7virus* genus. Their morphological and genomic properties allowed us to separate them into two different groups, group 1 (phages SH1 and SH2) and group 2 (phages SH3, SH4, and SH5). However, the two groups are co-linear and share conserved genomic organization. They are flanked by terminal repeats involved in concatemer formation, DNA packaging, and particle maturation (Chung et al., [@B16]). Despite their small size (close to 40 kb), the five phage genomes encode the usual modules with genes coding for proteins involved in DNA replication, transcription regulation, morphological proteins, lysis proteins, as well as DNA maturation and packaging. As such, they have very compact genomes with overlapping genes (Mendelman et al., [@B51]) as more than 90% of the five genome sequences were predicted to encode proteins. For phages SH1, SH3, and SH4 almost all the predicted structural proteins were detected by LC-MS/MS, showing that they are indeed transcribed and translated.

Another reason for sequencing the new phage genomes is to provide a clearer view about the dynamics of phage populations over space and time. Based on genomic and proteomic identification, we could define evolutionary relationships between these podophages (Brüssow and Hendrix, [@B10]). For example, phage T7 was isolated in 1945 (Delbrück, [@B20]), phage phiYeO3-12 from sewage in 1988 in Finland (Al-Hendy et al., [@B3]), phage K1F from sewage in 1984 in the USA (Scholl and Merril, [@B65]), and phage Dev2 was recently isolated from sewage in Slovakia (Kajsík et al., [@B37]). All five *C. freundii* phages characterized in this study were isolated from different sewage samples collected in Tunisia in 2014. These phages are geographically and temporally distant but from an evolutionary perspective, these phages likely shared a common ancestor.

As phages tend to coevolve with their bacterial hosts (Skurnik and Strauch, [@B69]) and *C. freundii* can produce enterotoxins (Guarino et al., [@B30]), we inspected the five phage genomes for the presence of host related genes, particularly those coding for known virulence-factors or integrase. No such genes were found, indicating that they are truly lytic phages as well as suggesting that they may be safe for therapeutic or prevention applications. Moreover, it was relatively easy to purify them and we obtained highly concentrated phage preparations. Conversely, these phages were inactivated at very acidic pH (2--3), suggesting that they may not survive in high numbers after passage through the gastrointestinal tract or in highly acidic foods. Others have shown that microencapsulation in alginate-chitosan microspheres significantly improved the survival and stability of phages under harsh acidic conditions (Ma et al., [@B50]). Finally, their limited host range suggests that they should be used in combination to maximize strain coverage. Of note, no CRISPR-Cas systems were found in the *C. freundii* genomes analyzed.

Taken altogether, the newly characterized *Podoviridae* phages SH1, SH2, SH3, SH4, and SH5 have appealing properties for prophylactic or therapeutic use to control the proliferation of *C. freundii* infections. The analyses of these *Citrobacter* phages also provided new evolutionary relationships with the expanding group of phages belonging to the *T7virus* genus, including with phages infecting *Cronobacter* and *Yersinia* species of the *Enterobacteriaceae* family.
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